Cargando…
First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple joints. It is associated with psoriasis and treated with synthetic and biologic drugs. OBJECTIVE: The objective of this study was to assess the outcomes of patients who received biologic therapy with tumor...
Autores principales: | da Silva, Michael Ruberson Ribeiro, dos Santos, Jéssica Barreto Ribeiro, Kakehasi, Adriana Maria, Almeida, Alessandra Maciel, Pimenta, Pedro Ricardo Kömel, Alvares-Teodoro, Juliana, Acurcio, Francisco de Assis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671557/ https://www.ncbi.nlm.nih.gov/pubmed/36043662 http://dx.doi.org/10.1590/1516-3180.2021.0434.R1.22022022 |
Ejemplares similares
-
Medication persistence for psoriatic arthritis in a Brazilian real-world setting
por: Ribeiro da Silva, Michael Ruberson, et al.
Publicado: (2019) -
Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil
por: Faria, Ronaldo José, et al.
Publicado: (2022) -
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System
por: de Souza, Elisa Neide Barbosa, et al.
Publicado: (2022) -
Medication adherence and persistence of psoriatic arthritis patients
treated with biological therapy in a specialty pharmacy in Brazil: a prospective
observational study
por: Souza, Ana F., et al.
Publicado: (2021) -
Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study
por: Souza, Kathiaja Miranda, et al.
Publicado: (2020)